The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons.

Mutations in the mitochondrial tRNA(Leu(UUR)) gene are associated with a large variety of human diseases through a largely undisclosed mechanism. The A3243G tRNA(Leu(UUR)) mutation leads to reduction of mitochondrial DNA (mtDNA)-encoded proteins and oxidative phosphorylation activity even when the cells are competent in mitochondrial translation. These two aspects led to the suggestion that a dominant negative factor may underlie the diversity of disease expression. Here we test the hypothesis that A3243G tRNA(Leu(UUR)) generates such a dominant negative gain-of-function defect through misincorporation of amino acids at UUR codons of mtDNA-encoded proteins. Using an anti-complex IV immunocapture technique and mass spectrometry, we show that the mtDNA-encoded cytochrome c oxidase I (COX I) and COX II exist exclusively with the correct amino acid sequences in A3243G cells in a misassembled complex IV. A dominant negative component therefore cannot account for disease phenotype, leaving tissue-specific accumulation by mtDNA segregation as the most likely cause of variable mitochondrial disease expression.

[1]  P. Chinnery,et al.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G. , 2007, American journal of human genetics.

[2]  S. Ackerman,et al.  Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration , 2006, Nature.

[3]  Tsutomu Suzuki,et al.  Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect. , 2006, Human molecular genetics.

[4]  A. Raap,et al.  Distinct nuclear gene expression profiles in cells with mtDNA depletion and homoplasmic A3243G mutation. , 2005, Mutation research.

[5]  Tsutomu Suzuki,et al.  Wobble modification deficiency in mutant tRNAs in patients with mitochondrial diseases , 2005, FEBS letters.

[6]  R. Aggeler,et al.  Focused proteomics: towards a high throughput monoclonal antibody-based resolution of proteins for diagnosis of mitochondrial diseases. , 2004, Biochimica et biophysica acta.

[7]  Takehiro Yasukawa,et al.  Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Howard T. Jacobs,et al.  Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.

[9]  G. Nijpels,et al.  Mitochondrial diabetes: molecular mechanisms and clinical presentation. , 2004, Diabetes.

[10]  H. Jacobs,et al.  Disorders of mitochondrial protein synthesis. , 2003, Human molecular genetics.

[11]  Alain Van Dorsselaer,et al.  Proteomic Consequences of a Human Mitochondrial tRNA Mutation beyond the Frame of Mitochondrial Translation* , 2003, Journal of Biological Chemistry.

[12]  M. King,et al.  The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. , 2003, Biochemistry.

[13]  M. Walker,et al.  Heteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells , 2003, Diabetologia.

[14]  Tsutomu Suzuki,et al.  Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases , 2002, The EMBO journal.

[15]  M. Mann,et al.  Analysis of Tyrosine Phosphorylation Sites in Signaling Molecules by a Phosphotyrosine-Specific Immonium Ion Scanning Method , 2002, Science's STKE.

[16]  C. Florentz,et al.  Comparative proteomics as a new tool for exploring human mitochondrial tRNA disorders. , 2002, Biochemistry.

[17]  J. Maassen,et al.  Molecular and clinical aspects of mitochondrial diabetes mellitus. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[18]  A. Hinnebusch,et al.  The tRNA‐binding moiety in GCN2 contains a dimerization domain that interacts with the kinase domain and is required for tRNA binding and kinase activation , 2001, The EMBO journal.

[19]  H Tanke,et al.  Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR. , 2001, Nucleic acids research.

[20]  C. Graff,et al.  Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes , 2000, Nature Genetics.

[21]  P. Tonali,et al.  Single-fiber PCR in MELAS(3243) patients: correlations between intratissue distribution and phenotypic expression of the mtDNA(A3243G) genotype. , 2000, American journal of medical genetics.

[22]  J. Enríquez,et al.  The Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episode Syndrome-associated Human Mitochondrial tRNALeu(UUR) Mutation Causes Aminoacylation Deficiency and Concomitant Reduced Association of mRNA with Ribosomes* , 2000, The Journal of Biological Chemistry.

[23]  D. Söll,et al.  Aminoacyl-tRNA synthesis. , 2000, Annual review of biochemistry.

[24]  K. Pfeiffer,et al.  Supercomplexes in the respiratory chains of yeast and mammalian mitochondria , 2000, The EMBO journal.

[25]  H. Jacobs,et al.  The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't. , 2000, Human molecular genetics.

[26]  S. Pääbo,et al.  Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. , 2000, Human molecular genetics.

[27]  Takehiro Yasukawa,et al.  Modification Defect at Anticodon Wobble Nucleotide of Mitochondrial tRNAsLeu(UUR) with Pathogenic Mutations of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes* , 2000, The Journal of Biological Chemistry.

[28]  J. Maassen,et al.  The Diabetes-associated 3243 Mutation in the Mitochondrial tRNALeu(UUR) Gene Causes Severe Mitochondrial Dysfunction without a Strong Decrease in Protein Synthesis Rate* , 1999, The Journal of Biological Chemistry.

[29]  J. Maassen,et al.  Functional and morphological abnormalities of mitochondria harbouring the tRNALeu(UUR) mutation in mitochondrial DNA derived from patients with maternally inherited diabetes and deafness (MIDD) and progressive kidney disease , 1999, Diabetologia.

[30]  Jens C. Brüning,et al.  Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression , 1999, Nature Genetics.

[31]  H. Jacobs,et al.  Mitochondrial tRNALeu isoforms in lung carcinoma cybrid cells containing the np 3243 mtDNA mutation. , 1998, Human molecular genetics.

[32]  W. Rossmanith,et al.  Impairment of tRNA processing by point mutations in mitochondrial tRNALeu(UUR) associated with mitochondrial diseases , 1998, FEBS letters.

[33]  I. Nonaka,et al.  Single muscle fiber analysis in patients with 3243 mutation in mitochondrial DNA: Comparison with the phenotype and the proportion of mutant genome , 1998, Journal of the Neurological Sciences.

[34]  L. Nijtmans,et al.  Assembly of cytochrome-c oxidase in cultured human cells. , 1998, European journal of biochemistry.

[35]  E. Uyama,et al.  Single muscle fiber analysis of myoclonus epilepsy with ragged‐red fibers , 1998, Muscle & nerve.

[36]  H. Jacobs,et al.  A tRNA suppressor mutation in human mitochondria , 1998, Nature Genetics.

[37]  H. Reichmann,et al.  Pathophysiology of the MELAS 3243 Transition Mutation* , 1997, The Journal of Biological Chemistry.

[38]  T. Kobayashi,et al.  In Situ Characterization of Islets in Diabetes With a Mitochondrial DNA Mutation at Nucleotide Position 3243 , 1997, Diabetes.

[39]  T. Tomizaki,et al.  The Whole Structure of the 13-Subunit Oxidized Cytochrome c Oxidase at 2.8 Å , 1996, Science.

[40]  R. Capaldi,et al.  Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. , 1996, Biochimica et biophysica acta.

[41]  M. Zeviani,et al.  Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. , 1996, Human molecular genetics.

[42]  A. Chomyn.  In vivo labeling and analysis of human mitochondrial translation products. , 1996, Methods in enzymology.

[43]  J. Enríquez,et al.  MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination , 1995, Nature Genetics.

[44]  M. Zwaan,et al.  Expression and fate of the nuclearly encoded subunits of cytochrome-c oxidase in cultured human cells depleted of mitochondrial gene products. , 1995, Biochimica et biophysica acta.

[45]  N. Larsson,et al.  Molecular genetic aspects of human mitochondrial disorders. , 1995, Annual review of genetics.

[46]  E. Schon,et al.  Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNALeu(UUR) gene , 1995, Muscle & nerve. Supplement.

[47]  G. Attardi,et al.  Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles , 1994, Molecular and cellular biology.

[48]  R. Sakuta,et al.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. , 1993, Biochemical and biophysical research communications.

[49]  M. Pembrey,et al.  Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA , 1992, The Lancet.

[50]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[51]  I. Nonaka,et al.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Schon,et al.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. , 1992, Molecular and cellular biology.

[53]  M. Deutscher,et al.  Channeling of aminoacyl-tRNA for protein synthesis in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  N. Bresolin,et al.  In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. , 1991, Molecular and cellular biology.

[55]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.